1-3 of 3
Daniel Backenroth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)

Kathleen Maignan, NP, Daniel Backenroth, Neil A. McQuarrie, Nicole G. Lipitz, Erin R. Williams, Kenneth R. Carson
Journal: Blood
Blood (2018) 132 (Supplement 1): 4734.
https://doi.org/10.1182/blood-2018-99-112153
Published: 2018
Journal Articles

Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Jeffrey A Zonder, MD, Keren Osman, MD, Miao Susanna, Daniel Backenroth, Daniel Otap, Wei-Yann Tsai, Siva Pregja, Shahzad Raza, MD, Vaishali Sanchorawala, MD, Heather J Landau, MD
Journal: Blood
Blood (2015) 126 (23): 3041.
https://doi.org/10.1182/blood.V126.23.3041.3041
Published: 2015
Journal Articles

Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light Chain (AL) Amyloidosis

Suzanne Lentzsch, MD PhD, Raymond L. Comenzo, MD, Keren Osman, MD, Kevin Zikaras, BS, Daniel Backenroth, Wei-Yann Tsai, Vaishali Sanchorawala, MD, Heather Landau, MD
Journal: Blood
Blood (2014) 124 (21): 3480.
https://doi.org/10.1182/blood.V124.21.3480.3480
Published: 2014